Moleculin Biotech Posts Investor Presentation under Reg FD

What Happened
Moleculin Biotech, Inc. (MBRX) filed a Form 8-K on August 31, 2026 (Item 7.01) to disclose that it is using an investor presentation dated August 31, 2026. The presentation has been posted on the company’s website and is furnished as Exhibit 99.1 to the filing. The 8-K also includes the interactive cover page data (Inline XBRL) under Item 9.01.

Key Details

• Filing date: August 31, 2026.
• Presentation dated: August 31, 2026, furnished as Exhibit 99.1.
• Disclosure made under Item 7.01 (Regulation FD) and exhibits listed under Item 9.01.
• Interactive cover page file included (Exhibit 104, Inline XBRL).

Why It Matters
This filing ensures Moleculin’s investor presentation is publicly available and complies with Regulation FD (which aims to prevent selective disclosure). Investors and analysts can review the posted presentation for the company’s latest corporate information; the 8-K itself does not report earnings, financial results, or other separate financial statements. Review the attached Exhibit 99.1 on the company website or in the SEC filing for specific program, timeline, or business updates.